Related Experiment Video

Updated: May 25, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Might salicylate exert benefits against childhood cancer?

G Morgan1, Ji Johnsen

  • 1Fellow of the Royal Institute for Public Health, National Health Service for Wales, Wales, UK.

Ecancermedicalscience
|January 26, 2012
PubMed

Insights

Aspirin (acetylsalicylate) shows potential in preventing childhood cancers by inhibiting inflammatory prostaglandins and cancer cell growth. Further research is recommended to explore this chemopreventive strategy.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Childhood cancers encompass diverse diseases.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin (acetylsalicylate) have demonstrated chemopreventive potential.
  • Research has not fully explored NSAIDs for childhood cancer prevention.

Purpose of the Study:

  • To hypothesize the chemopreventive potential of salicylate in childhood cancers.
  • To review existing evidence supporting salicylate's anti-cancer properties.

Main Methods:

  • Literature review of salicylate's effects on inflammatory prostaglandins.
  • Examination of salicylate's efficacy in pre-clinical cancer models.
  • Consideration of dietary intake of salicylate.

Main Results:

  • Salicylate inhibits inflammatory prostaglandins, which can promote cancer cell growth.
  • Salicylate demonstrates inhibitory effects on cancer cell proliferation in pre-clinical studies.
  • Salicylate is a naturally occurring compound found in fruits and vegetables.

Conclusions:

  • Salicylate presents a plausible hypothesis for childhood cancer chemoprevention.
  • Further research is warranted to investigate salicylate's role in preventing childhood cancers.
  • Dietary salicylate intake may contribute to its potential chemopreventive effects.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...